Pretreatment of microglia with glioma-conditioned medium (GCM) strongly reduces lipopolysaccharide (LPS)-induced inflammatory gene expression (c-Myc, Mark1), whereby microglia acquire “transcriptional memory”. The gene discussed is MYC; the disease is glioma.